Cite
Glucocorticoids’ treatment impairs the medium-term immunogenic response to SARS-CoV-2 mRNA vaccines in Systemic Lupus Erythematosus patients
MLA
Silvia Garcia-Cirera, et al. “Glucocorticoids’ Treatment Impairs the Medium-Term Immunogenic Response to SARS-CoV-2 MRNA Vaccines in Systemic Lupus Erythematosus Patients.” Scientific Reports, vol. 12, no. 1, Aug. 2022, pp. 1–9. EBSCOhost, https://doi.org/10.1038/s41598-022-18996-x.
APA
Silvia Garcia-Cirera, Joan Calvet, Antoni Berenguer-Llergo, Edwards Pradenas, Silvia Marfil, Marta Massanella, Lourdes Mateu, Benjamin Trinité, Maria Llop, Marta Arévalo, Carlos Galisteo, Cristóbal Orellana, Rafael Gómez, María Nieves Gómez-Gerique, Inma Carmona, Bonaventura Clotet, Julià Blanco, & Jordi Gratacós. (2022). Glucocorticoids’ treatment impairs the medium-term immunogenic response to SARS-CoV-2 mRNA vaccines in Systemic Lupus Erythematosus patients. Scientific Reports, 12(1), 1–9. https://doi.org/10.1038/s41598-022-18996-x
Chicago
Silvia Garcia-Cirera, Joan Calvet, Antoni Berenguer-Llergo, Edwards Pradenas, Silvia Marfil, Marta Massanella, Lourdes Mateu, et al. 2022. “Glucocorticoids’ Treatment Impairs the Medium-Term Immunogenic Response to SARS-CoV-2 MRNA Vaccines in Systemic Lupus Erythematosus Patients.” Scientific Reports 12 (1): 1–9. doi:10.1038/s41598-022-18996-x.